Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2 Endocrine 1

Conditions

Differentiated Thyroid Carcinoma 1

Interventions

Specimen Handling 13 Magnetic Resonance Spectroscopy 13 lutetium Lu 177 dotatate 10 cabozantinib 6 Nivolumab 5 X-Rays 4 Ipilimumab 4 pembrolizumab 3 olaparib 3 fludarabine 3 Phantoms, Imaging 3 Everolimus 3 Etoposide 3 Cyclophosphamide 3 Cisplatin 3 Carboplatin 3 CTLA-4 Antigen 3 gallium Ga 68 dotatate 2 fluorodopa F 18 2 aldesleukin 2 Temozolomide 2 Lutetium-177 2 Lutetium 2 Irinotecan 2 Fluorodeoxyglucose F18 2 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 2 trametinib 1 tivozanib 1 tipifarnib 1 selpercatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Iodine-124 × Endocrine × 30 days × Clear all

NCT01704586 2026-05-12

CLERAD-PROBE

University of Wuerzburg

Phase NA Active not recruiting

EndocrineHead & Neck

Differentiated Thyroid Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡